Immune cells can be altered to help fight inflammatory diseases, research finds

(Medical Xpress)—A fundamental mechanism controlling cells of the human immune system could be key to helping fight inflammatory diseases such as rheumatoid arthritis and psoriasis, new research at the University of Dundee has found.

The research by Dr Kris Clark, in the Medical Research Council Unit (MRC-PPU) at Dundee, concentrated on the activity of macrophages, which are cells of the immune system that defend the body against infection by bacteria and viruses.

Dr Clark found that an enzyme called SIK is active in suppressing the production of anti-inflammatory molecules. By 'switching off' the function of SIK within the cell, he was able to greatly enhance the production of beneficial anti-inflammatory molecules.

The research suggests that drugs that switch off SIK may improve current therapies for treating inflammatory diseases, such as and psoriasis.

"These are very exciting times for our research," said Dr Clark. "This discovery represents the first link between SIK and inflammation. My immediate future goal is to characterize in more detail the roles that SIK plays in the immune system and how they are affected by compounds that switch off this enzyme."

The research has been published in the .

Macrophages are cells of the immune system that defend the body against infection by bacteria and viruses. However, once these invading pathogens have been destroyed, the inflammatory responses triggered by macrophages have to be stopped, to avoid the development of .

Macrophages also play key roles in terminating the by switching on the production of so-called anti-inflammatory molecules.

Kris discovered that the production of anti-inflammatory molecules by is prevented by an enzyme called SIK and that, by turning off the function of SIK within the cell, he was able to greatly enhance the production of beneficial anti-inflammatory molecules while stopping the production of the molecules that cause inflammation.

Working with the Drug Discovery Unit at Dundee, Dr Clark has now started to develop molecules which could provide the basis for drugs to turn off SIK.

"My studies have greatly benefitted from working in the multi-disciplinary and collegial environment that has been built up in the MRC Unit, the Scottish Institute for Cell Signalling and the College of Life Sciences at Dundee," said Dr Clark. "My interactions with the scientists who work here and the advice they have given me has not only been invaluable for this project, but also most enjoyable."

Related Stories

Scientists shine new light on inflammatory diseases

Mar 16, 2008

Investigators at Hospital for Special Surgery have identified a new mechanism involved in the pathogenesis of inflammatory diseases such as rheumatoid arthritis. The mechanism may also shed some light on why gene therapy ...

Recommended for you

A cause of age-related inflammation found

Nov 06, 2014

As animals age, their immune systems gradually deteriorate, a process called immunosenescence. It is associated with systemic inflammation and chronic inflammatory disorders, as well as with many cancers. ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.